Role of Spinal Monocarboxylate Transporter-2 in Development of Acute Inflammatory Pain in Mice
He Jianhua,Xu li,Ruan Jiaping,Shen Y,Gu Xiaoping,Ma zhengliang
DOI: https://doi.org/10.3760/cma.j.issn.0254-1416.2016.01.018
2016-01-01
Abstract:Objective To investigate the role of spinal monocarboxylate transporter-2 (MCT-2) in the development of acute inflammatory pain in mice.Methods Thirty-two male adult Kunming mice,weighing 20-25 g,were divided into 4 groups (n =8 each) using a random number table:control group (group C),inflammatory pain group (group IP),MCT-2 inhibitor α-cyano-4-hydroxy-cinnamate group (group 4-CIN),and dimethyl sulfoxide group (group D).In IP,4-CIN and DMSO groups,the inflammatory pain was induced by injection of 5％ formalin 10 μl into the plantar surface of the right hindpaw.At 30 min before formalin injection,the artificial cerebrospinal fluid,4-CIN (100 μmol) and 10％ DMSO 5 μl were injected intrathecally over l0 s in IP,4-CIN and DMSO groups,respectively.Pain behavior was scored within 60 min after establishment of the model.The lumbar segment of the spinal cord was harvested at 60 min after establishment of the model for detection of the expression of MCT-2 by Western blot analysis.Results Compared with group C,the pain behavior score was significantly increased in phase Ⅰ and phase Ⅱ,and the expression of MCT-2 was up-regulated in IP,4-CIN and DMSO groups (P＜0.01).Compared with group IP,the pain behavior score was significantly decreased in phase Ⅰ and phase Ⅱ,and the expression of MCT-2 was down-regulated in group 4-CIN (P＜0.05),and no significant change was found in the parameters mentioned above in group DMSO (P＞0.05).Conclusion Spinal MCT-2 is involved in the development of acute inflammatory pain in mice.